| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |